-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.00155.81% Upside
TriSalus Life Sciences, Inc. Frequently Asked Questions
-
What analysts cover TriSalus Life Sciences, Inc.?
TriSalus Life Sciences, Inc. has been rated by research analysts at Oppenheimer, Canaccord Genuity in the past 90 days.